Skip to main content
Log in

Molecular variation at the apolipoprotein B gene locus in relation to lipids and cardiovascular disease: a systematic meta-analysis

  • Original Investigation
  • Published:
Human Genetics Aims and scope Submit manuscript

Abstract

Apolipoprotein B (apoB) is the sole protein component of low-density lipoprotein (LDL) and is thought to play an important role in atherogenesis. We performed a meta-analysis of the associations between the three most frequently investigated polymorphisms (XbaI, signal peptide insertion/deletion, EcoRI) in the apolipoprotein B (APOB) gene, lipid parameters, and the risk of ischemic heart disease (IHD). We restricted our analysis to Caucasians. Homozygotes for the XbaI X+ allele had significantly elevated levels of LDL cholesterol (LDL-C) and apoB, but a decreased risk (OR=0.80; 95%CI: 0.66–0.96) of IHD. Homozygosity for the signal peptide deletion allele was associated with similarly increased levels of LDL-C and apoB, and with an increased risk of IHD (OR=1.30; 95%CI: 1.08–1.58). Subjects homozygous for the rare EcoRI allele had significantly decreased levels of total and LDL cholesterol, but unaltered risk of IHD. We conclude that all three polymorphic apoB sites are associated with altered lipid levels, but not necessarily with a consistently altered risk of IHD. These data suggest that the relationship between apoB levels, hypercholesterolemia and IHD risk cannot have a simple molecular basis in the apoB gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  • Aalto-Setala K, Palomaki H, Miettinen H, Vuorio A, Kuusi T, Raininko, Salonen O, Kaste M, Kontula K (1998) Genetic risk factors and ischaemic cerebrovascular disease: role of common variation of the genes encoding apolipoproteins and angiotensin-converting enzyme. Ann Med 30:224–233

    CAS  PubMed  Google Scholar 

  • Abbey M, Hirata F, Chen GZ, Ross R, Noakes M, Belling B, Clifton P, Nestel PJ (1995) Restriction fragment length polymorphism of the apolipoprotein B gene and response to dietary fat and cholesterol. Can J Cardiol 11 (Suppl G):79G–85G

    CAS  PubMed  Google Scholar 

  • Benes P, Muzik J, Benedik J, Elbl L, Znojil V, Vacha J (2000a) Apolipoprotein B signal peptide polymorphism in relation to lipids and diabetes in male CAD patients. Atherosclerosis 152:257–258

    Article  CAS  PubMed  Google Scholar 

  • Benes P, Muzik J, Benedik J, Frelich M, Elbl L, Vasku A, Znojil V, Vacha J (2000b) Single effects of apolipoprotein B, (a), and E polymorphisms and interaction between plasminogen activator inhibitor-1 and apolipoprotein(a) genotypes and the risk of coronary artery disease in Czech male caucasians. Mol Genet Metab 69:137–143

    Google Scholar 

  • Bohn M, Bakken A, Erikssen J, Berg K (1993) XbaI polymorphism in DNA at the apolipoprotein B locus is associated with myocardial infarction (MI). Clin Genet 44:241–248

    CAS  PubMed  Google Scholar 

  • Bohn M, Bakken A, Erikssen J, Berg K (1994) The apolipoprotein B signal peptide insertion/deletion polymorphism is not associated with myocardial infarction in Norway. Clin Genet 45:255–259

    CAS  PubMed  Google Scholar 

  • Boren J, Ekstrom U, Agren B, Nilsson-Ehle P, Innerarity TL (2001) The molecular mechanism for the genetic disorder familial defective apolipoprotein B100. J Biol Chem 276:9214–9218

    Article  CAS  PubMed  Google Scholar 

  • Campbell EG, Clarridge BR, Gokhale M, Birenbaum L, Hilgartner S, Holtzman NA, Blumenthal D (2002) Data withholding in academic genetics. Evidence from a national survey. JAMA 287:473–480

    Article  PubMed  Google Scholar 

  • Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels. JAMA 256:2835–2838

    CAS  PubMed  Google Scholar 

  • Corbo RM, Vilardo T, Mantuano E, Ruggeri M, Gemma AT, Scacchi R (1997) Apolipoproteins B and E, and angiotensin I-converting enzyme (ACE) genetic polymorphisms in Italian women with coronary artery disease (CAD) and their relationships with plasma lipid and apolipoprotein levels. Clin Genet 52:77–82

    CAS  PubMed  Google Scholar 

  • Deeb SS, Failor RA, Brown BG, Brunzell JD, Albers JJ, Motulsky AG, Wijsman E (1992) Association of apolipoprotein B gene variants with plasma apoB and low density lipoprotein (LDL) cholesterol levels. Hum Genet 88:463–470

    CAS  PubMed  Google Scholar 

  • Delghandi M, Thangarajah R, Nilsen M, Grimsgaard S, Bonaa KH, Tonstad S, Jorgensen L (1999) DNA polymorphisms of the apolipoprotein B gene (XbaI, EcoRI, and MspI RFLPs) in Norwegians at risk of atherosclerosis and healthy controls. Acta Cardiol 54:215–225

    CAS  PubMed  Google Scholar 

  • Dunning AM, Renges HH, Hamsten A, Talmud P, Humphries S (1993) A postulated phylogenetic tree for the human apolipoprotein B gene: unpredicted haplotypes are associated with elevated apo B levels. Biochim Biophys Acta 1165:271–278

    Article  CAS  PubMed  Google Scholar 

  • Gaffney D, Freeman DJ, Shepherd J, Packard CJ (1993) The ins/del polymorphism in the signal peptide of apolipoprotein B has no effect on lipid parameters. Clin Chim Acta 218:131–138

    Article  CAS  PubMed  Google Scholar 

  • Gardemann A, Ohly D, Fink M, Katz N, Tillmanns H, Hehrlein FW, Haberbosch W (1998) Association of the insertion/deletion gene polymorphism of the apolipoprotein B signal peptide with myocardial infarction. Atherosclerosis 141:167–175

    Article  CAS  PubMed  Google Scholar 

  • Glisic S, Prljic J, Radovanovic N, Alavantic D (1997) Study of apoB gene signal peptide insertion/deletion polymorphism in a healthy Serbian population: no association with serum lipid levels. Clin Chim Acta 263:57–65

    Article  CAS  PubMed  Google Scholar 

  • Greenland S, Rothman KJ (1998) Introduction to stratified analysis. In: Williams A, Wilkins B (eds) Modern epidemiology. Lippincott, Philadelphia, pp 253–279

  • Hansen PS, Gerdes LU, Klausen IC, Gregersen N, Faergeman O (1993) Polymorphisms in the apolipoprotein B-100 gene contributes to normal variation in plasma lipids in 464 Danish men born in 1948. Hum Genet 91:45–50

    Google Scholar 

  • Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic Press, San Diego

  • Hixson JE, McMahan CA, McGill HC Jr, Strong JP (1992) Apo B insertion/deletion polymorphisms are associated with atherosclerosis in young black but not young white males. Arterioscler Thromb 12:1023–1029

    CAS  PubMed  Google Scholar 

  • Hosking JL, Bais R, Sobecki SK, Tallis GA, Bradley J, Thomas DW (1992) Lipid parameters and apolipoprotein B RFLP studies: comparison of normal and coronary heart disease groups as defined by angiography. Clin Biochem 25:303–308

    CAS  Google Scholar 

  • Ioannidis JPA, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG (2001) Replication validity of genetic association studies. Nat Genet 29:306–309

    Article  CAS  PubMed  Google Scholar 

  • Iso H, Harada S, Shimamoto T, Folsom AR, Koike K, Sato S, Iida M, Komachi Y (1996) Polymorphism of the apolipoprotein B gene and blood lipid concentrations in Japanese and Caucasian population samples. Atherosclerosis 126:233–241

    Article  CAS  PubMed  Google Scholar 

  • Lopez-Miranda J, Ordovas JM, Ostos MA, Marin C, Jansen S, Salas J, Blanco-Molina A, Jimenez-Pereperez JA, Lopez-Segura F, Perez-Jimenez F (1997) Dietary fat clearance in normal subjects is modulated by genetic variation at the apolipoprotein B gene locus. Arterioscler Thromb Vasc Biol 17:1765–1773

    CAS  PubMed  Google Scholar 

  • Lopez-Miranda J, Marin C, Castro P, Gomez P, Gonzalez-Amieva A, Paz E, Bravo D, Ordovas JM, Jimenez-Pereperez J, Perez-Jimenez F (2000) The effect of apolipoprotein B XbaI polymorphism on plasma lipid response to dietary fat. Eur J Clin Invest 30:678–684

    Article  CAS  PubMed  Google Scholar 

  • Louhija J, Miettienen HE, Kontula K, Tikkanen MJ, Miettinen TA, Tilvis RS (1994) Aging and genetic variation of plasma apolipoproteinns. Arterioscler Thromb 14:1084–1089

    CAS  Google Scholar 

  • Machado MO, Hirata MH, Bertolami MC, Hirata RDC (2001) Apo B gene haplotype is associated with lipid profile of higher risk for coronary heart disease in Caucasian Brazilian men. J Clin Lab Anal 15:19–24

    Article  CAS  PubMed  Google Scholar 

  • Marshall HW, Morrison LC, Wu LL, Anderson JL, Corneli PS, Stauffer, DM, Allen A, Karagounis LA, Ward RH (1994) Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study. Circulation 89:567–577

    CAS  PubMed  Google Scholar 

  • Miettinen HE, Korpela K, Hamalainen L, Kontula K (1994) Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet 94:189–192

    CAS  PubMed  Google Scholar 

  • Miremadi S, Sniderman A, Frohlich J (2002) Can measurement of serum apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorders? Clin Chem 48:484–488

    CAS  PubMed  Google Scholar 

  • Moreel JF, Roizes G, Evans AE, Arveiler D, Cambou JP, Souriau C, Parra HJ, Desmarais E, Fruchart JC, Ducimetiere P, Cambien F (1992) The polymorphism ApoB/4311 in patients with myocardial infarction and controls: the ECTIM Study. Hum Genet 89:169–175

    CAS  PubMed  Google Scholar 

  • Nieminen MS, Mattila KJ, Aalto-Setala K, Kuusi T, Kontula K, Kauppinen-Makelin R, Ehnholm C, Jauhiainen M, Valle M, Taskinen MR (1992) Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. Arterioscler Thromb 12:58–69

    CAS  PubMed  Google Scholar 

  • Pajukanta PE, Valsta LM, Aro A, Pietinen P, Helio T, Tikkanen MJ (1996) The effects of the apolipoprotein B signal peptide (ins/del) and XbaI polymorphisms on plasma lipid responses to dietary challenge. Atherosclerosis 122:1–10

    Article  CAS  PubMed  Google Scholar 

  • Peacock R, Dunning A, Hamsten A, Tornvall P, Humphries S, Talmud P (1992) Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: a study of young myocardial infarction survivors and healthy population-based individuals. Atherosclerosis 92:151–164

    CAS  PubMed  Google Scholar 

  • Peters RJ, Boekholdt SM (2002) Gene polymorphisms and the risk of myocardial infarction—an emerging relation. N Engl J Med 347:1963–1965

    Article  PubMed  Google Scholar 

  • Pouliot MC, Despres JP, Dionne FT, Vohl MC, Moorjani S, Prud'homme D, Bouchard C, Lupien PJ (1994) Apo B-100 gene EcoRI polymorphism. Realtions to plasma lipoprotein changes associated with abdominal visceral obesity. Arterioscler Thromb 14:527–533

    CAS  PubMed  Google Scholar 

  • Povey S, Lovering R, Bruford E, Wright M, Lush M, Wain H (2001) The HUGO Gene Nomenclature Committee (HGNC). Hum Genet 109:678–680

    CAS  PubMed  Google Scholar 

  • Randall LL, Hardy SJ (1989) Unity in functions in the absence of consensus in sequence: role of leader peptides in export. Science 243:1156-1159

    CAS  PubMed  Google Scholar 

  • Salazar LA, Hirata MH, Giannini SD, Forti N, Diament J, Lima TM, Hirata RDC (2000) Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease. Clin Chim Acta 300:139–149

    Article  CAS  PubMed  Google Scholar 

  • Series JJ, Gaffney D, Packard CJ, Shepherd J (1993) Frequency of the XbaI, EcoRI, PvuII and MspI polymorphisms of the apolipoprotein B gene in relation to hypercholesterolaemia in the general population. Clin Chim Acta 215:89–98

    Article  CAS  PubMed  Google Scholar 

  • Sijbrands EJ, Westendorp R, Lombardi P, Havekes L, Frants A, Kastelein JJ, Smelt AH (2000) Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia. Atherosclerosis 149:421–425

    Article  CAS  PubMed  Google Scholar 

  • Sijbrands EJ, Westendorp RG, Defesche JC, Meier PH de, Smelt AH, Kastelein JJ (2001) Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study. BMJ 822:1019–1023

    Article  Google Scholar 

  • Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, Boren J (2002) Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417:750–754

    Article  PubMed  Google Scholar 

  • Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I, Walldius G (2003) Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 361:777–780

    Article  CAS  PubMed  Google Scholar 

  • Turner PR, Talmud PJ, Visvikis S, Ehnholm C, Tiret L (1995) DNA polymorphisms of the apoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: European Atherosclerosis Research Study. Atherosclerosis 116:221–234

    Article  CAS  PubMed  Google Scholar 

  • Ukkola O, Savolainen MJ, Salmela PI, Xyz DK von, Kesaniemi YA (1993) Apolipoprotein B gene DNA polymorphisms are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus. Clin Genet 44:177–184

    CAS  PubMed  Google Scholar 

  • Umans-Eckenhausen MA, Sijbrands EJ, Kastelein JJ, Defesche JC (2002) Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation 106:3031–3036

    Article  PubMed  Google Scholar 

  • Vilella E, Balanya J, Masana L, Marsal S, La Ville AE, Turner PR (1992) Low density lipoprotein ligand-receptor interactions in normal healthy individuals characterized by their XbaI apolipoprotein B DNA polymorphism. Atherosclerosis 93:145–153

    CAS  PubMed  Google Scholar 

  • Visvikis S, Cambou JP, Arveiler D, Evans AE, Parra HJ, Aguillon D, Fruchart JC, Siest G, Cambien F (1993) Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls. "The ECTIM study". Hum Genet 90:561–565

    CAS  PubMed  Google Scholar 

  • Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358:2026–2033

    Article  CAS  PubMed  Google Scholar 

  • Wick U, Witt E, Engel W (1995) Restriction fragment length polymorphisms at the apoprotein genes AI, CIII and B-100 and in the 5' flanking region of the insulin gene as possible markers of coronary heart disease. Clin Genet 47:184–190

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors gratefully acknowledge all authors who provided additional unpublished information regarding publications included in this review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Matthijs Boekholdt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boekholdt, S.M., Peters, R.J.G., Fountoulaki, K. et al. Molecular variation at the apolipoprotein B gene locus in relation to lipids and cardiovascular disease: a systematic meta-analysis. Hum Genet 113, 417–425 (2003). https://doi.org/10.1007/s00439-003-0988-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00439-003-0988-3

Keywords

Navigation